Ambry Genetics Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ambry Genetics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10808
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorders among others. It offers bioinformatics solutions for transcriptomic, genomic, and epigenomic data analysis. Ambry Genetics specializes in providing whole transcriptome and targeted RNA analysis, tumor genomic profiling, immuno-oncology biomarker analysis, and ctDNA analysis. It also offers contract research services to the biotech and pharmaceutical industries. The company caters to academic institutions, researchers, healthcare professionals, and hospitals. Ambry Genetics is headquartered in Aliso Viejo, California, the US.

Ambry Genetics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ambry Genetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ambry Genetics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ambry Genetics Enters into Partnership with inviCRO 11
Acquisition 12
Konica Minolta Acquires Ambry Genetics 12
Ambry Genetics Acquires Progeny Software 14
Ambry Genetics Corp – Key Competitors 15
Ambry Genetics Corp – Key Employees 16
Ambry Genetics Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Aug 21, 2018: Konica Minolta Precision Medicine appoints Dr. John E. Niederhuber as scientific advisory board chairman 18
Jun 20, 2018: Invicro and Ambry Genetics Appoint Dr. Kenneth Bloom as Chief Medical Officer of Advanced Pathology and Genomic Services 19
Jan 12, 2018: Ambry Appoints Linh H. Le as New Chief Operating Officer 20
Dec 14, 2017: Ambry Names Tom Schoenherr as Chief Commercial Officer 21
Government and Public Interest 22
Apr 18, 2017: Ambry Genetics Recruits Patient Cohorts to Discover New Links between Genes and Autism 22
Other Significant Developments 23
Jun 12, 2018: Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for People with Suspected Hereditary ATTR Amyloidosis 23
Feb 21, 2017: Ambry Genetics Launches New Site for Cohort Recruitment 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Key Facts 2
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ambry Genetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ambry Genetics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Ambry Genetics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ambry Genetics Enters into Partnership with inviCRO 11
Konica Minolta Acquires Ambry Genetics 12
Ambry Genetics Acquires Progeny Software 14
Ambry Genetics Corp, Key Competitors 15
Ambry Genetics Corp, Key Employees 16
Ambry Genetics Corp, Subsidiaries 17

List of Figures
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ambry Genetics Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ambry Genetics Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Public Broadcasting Service:企業の戦略・SWOT・財務分析
    SummaryPublic Broadcasting Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Agile Therapeutics Inc (AGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Krispy Kreme Doughnuts, Inc.の企業概要及び財務/SWOT分析
    Krispy Kreme Doughnuts, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Krispy Kreme Doughnuts, Inc. annual and quarterly forecasts made by stock market experts. The rep …
  • Aileron Therapeutics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aileron Therapeutics, Inc. Merg …
  • CJ Corporation:企業概要・SWOT・財務分析
    Summary Canadean's "CJ Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • Petrolympic Ltd (PCQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • QIAGEN N.V.:企業のM&A・提携・投資分析
    QIAGEN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QIAGEN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Soda Aromatic Co., Ltd. (4965):企業財務及び戦略的SWOT分析
    Summary Soda Aromatic Co., Ltd. (Soda Aromatic) a subsidiary of Toray Industries, Inc. is a chemical company that offers fragrances, feed flavors, tobacco flavors, flavors, aroma chemicals, industrial chemicals, and other products. The company manufactures and markets fragrances such as perfume, col …
  • Stantec, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Stantec, Inc. Mergers and Acqui …
  • TGK-9 OAO:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TGK-9 OAO Mergers and Acquisiti …
  • LG-Ericsson Co., Ltd. (Formerly LG-Nortel Co., Ltd.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LG-Ericsson Co., Ltd. (Formerly …
  • Generale de Sante SA (GDS):企業概要、財務及び戦略的SWOT分析
    Summary Generale de Sante SA (GDS) is a pharmaceuticals and healthcare services provider. The company operates a network of private hospitals and clinics. It provides services in the areas of medicine, surgery, obstetrics, psychiatry, alcoholism, obesity and cancer treatments, and radiation therapy. …
  • Orthofix International N.V. (OFIX)-医療機器分野:企業M&A・提携分析
    Summary Orthofix International N.V. (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic. Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation prod …
  • First Niagara Financial Group, Inc. (FNFG):企業の財務及び戦略的SWOT分析
    Summary First Niagara Financial Group, Inc. (First Niagara) is a financial service provider that offers banking and financial services. The firmoffers services in categories such as bank, plan and invest, borrow, and insure and protect. Its banking services include personal banking, commercial banki …
  • Power Grid Corporation of India Limited (POWERGRID):企業財務及び戦略的SWOT分析
    Summary Power Grid Corporation of India Limited (POWERGRID) is a power transmission company that develops integrated national grid and associates in the flagship programme of Govt. of India to provide power. The company’s activities include planning, coordination, supervision and control over inter- …
  • BASF:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BASF Mergers and Acquisitions ( …
  • INTAGE Inc. (4326):企業財務及び戦略的SWOT分析
    Summary INTAGE Inc. (INTAGE), formerly Marketing Intelligence Corporation is a business and consumer services company that offers marketing research services. The company offers services which include campaigns, call to action services, providing and developing ads, website designing, providing bran …
  • Pele Mountain Resources Inc. (GEM):企業の財務及び戦略的SWOT分析
    Summary Pele Mountain Resources Inc. (Pele Mountain) is a mineral exploration company that acquires, explores and develops monazite, and rare earth metals. The company’s eco ridge project offers products which include rare earth oxides. Its projects include eco ridge mine rare earths and uranium, an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆